Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — H1 2013 Earnings Presentation

8 slides from Novonesis A/s Class B's earnings presentation, Aug 9, 2013

  1. Slide 1: Conference Call 1H 2013

    CONFERENCE CALL 1H 2013 August 9, 2013

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement This presentation and its related comments contain forward-looking statements, including financial expectations. Forward-looking statements are by their very nature associated with risks and uncertainties that may cause actual results to differ materially from expectations. The

  3. Slide 3: 1H 2013 summary

    1H 2013 summary First-half sales as expected; FY outlook for Quarterly sales 2011-2013, DKKm organic sales growth maintained (5-8%) 3.025 • 6% organic sales growth in the first half driven by 2.851 2.838 2.811 2.845 2.734 Household Care and Agriculture & Feed 2.692 2.692 2.589 2.537 • Sales growth p

  4. Slide 4: Sales & Markets

    Sales & Markets First-half sales as expected following solid Q2 sales Sales by industry, DKKm growth across industries 1H 2013 1H 2012  1H 2013 sales: DKK +5%, LCY & org: +6%  Q2 2013 sales: DKK +6%, LCY +8%, org: +7% Household 2.078 +6%/+7% Q2: +8% Care 1.962 • Household Care remained the stronge

  5. Slide 5: In Detail: 2013 US Fuel Ethanol Production

    In Detail: 2013 US Fuel Ethanol Production • Novozymes assumes flat Quarterly US fuel ethanol production, production growth 2013/2012 2012 & 2013 - Different production pattern in 2013 vs. 2012 due to the 2012 Actual 2013 Actual/estimates drought Bn. gallons 3,6 • Novozymes guides for growth 3,5 in

  6. Slide 6: Innovation

    Innovation • 2013 to be a strong year from a product launch perspective across industries • Important launches in the first half of 2013 in HHC (exclusive and non-exclusive) • Bioenergy case: Innovation is key to increasing enzyme use cost and retaining leadership position. New technology package de

  7. Slide 7: 1H 2013 Financial Performance & FY 2013 Outlook

    1H 2013 Financial Performance & FY 2013 Outlook Satisfactory 1H 2013 earnings Realized 1H Outlook Outlook • Gross margin up 0.7 %-point Key financials 2013 August 9 April 25 • EBIT margin up 0.4 %-point Sales growth, • Despite negative contribution from +5% 5-7% 5-8% DKK currencies, startup in Nebra

  8. Slide 8: Novozymes: Rethink Tomorrow

    novozymes’ Rethink Tomorrow

Novozymes — H1 2013 Earnings Presentation on 6ix